International Business Machines (IBM) Stock: Price, Chart & AI Analysis

Key Takeaways

• IBM shares fell approximately 14.6% over the last 30 days, driven primarily by a historic single-day crash of 25.2% on July 14 following a preliminary second-quarter earnings warning.
• The stock's worst daily decline in at least 56 years erased roughly $68 billion in market value after the company preannounced Q2 revenue and earnings that missed Wall Street consensus estimates.
• CEO Arvind Krishna attributed the shortfall to enterprise clients unexpectedly shifting capital expenditures toward AI hardware infrastructure — servers, storage, and memory — at the expense of IBM's software and mainframe offerings.
• Software revenue growth decelerated sharply to 5% from 11% in the prior quarter, while the consulting segment was flat and infrastructure revenue contracted 7%.
• Multiple analysts downgraded or cut price targets in the aftermath, though the broader consensus remains a Moderate Buy ahead of IBM's full Q2 report scheduled for July 22.

International Business Machines (IBM) Company Overview and Market Position

International Business Machines Corporation, universally known as IBM, is a global technology and consulting enterprise headquartered in Armonk, New York. With roots tracing back to 1911, IBM has reinvented itself multiple times across computing eras and today generates revenue through three primary segments: Software, Consulting, and Infrastructure. The Software division — anchored by the Red Hat hybrid cloud platform acquired in 2019 — provides enterprise-grade solutions spanning automation, data analytics, AI, and security. The Consulting unit helps large organizations navigate digital transformation, while the Infrastructure segment encompasses IBM's storied mainframe business, including the z17 system designed for AI workloads. IBM has invested more than $50 billion in strategic acquisitions since 2018, including Red Hat, HashiCorp, and Confluent, positioning itself as an enterprise AI and hybrid cloud leader. The company is also a pioneer in quantum computing, pledging over $10 billion toward delivering the first large-scale fault-tolerant quantum computer by 2029. Investors track IBM closely for its dividend reliability — the company has raised its quarterly payout for 31 consecutive years — and for its role as a bellwether of enterprise technology spending.

International Business Machines (IBM) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 calendar days, IBM shares declined roughly 14.6%, falling from a closing price of $249.10 on June 18 to $212.67 on July 17. The decline was not gradual — it was concentrated in a single catastrophic session on July 14, when the stock plunged 25.2% following the unexpected release of disappointing preliminary second-quarter results. That one-day evaporation of approximately $68 billion in market capitalization marked IBM's worst trading day since at least 1968.

The quarterly picture is starker. IBM reached its 52-week high of $332.46 on June 2, capping a remarkable multi-year rally that had seen shares more than double over five years. From that peak, the stock has shed roughly 36% of its value. The first quarter of 2026 had been exceptionally strong: revenue grew 9.5% to $15.92 billion, software revenue jumped 11%, and infrastructure surged 15% on the back of the z17 mainframe cycle. That momentum evaporated when the preliminary Q2 figures revealed across-the-board deceleration, challenging the premium valuation the market had assigned to IBM's turnaround narrative.

What Drove IBM Stock Price in the Last 30 Days

The defining catalyst was IBM's July 14 preannouncement of preliminary Q2 2026 results, released eight days ahead of its scheduled earnings report. The company disclosed revenue of $17.2 billion — up just 1% year-over-year and roughly $660 million below the LSEG consensus of $17.86 billion. Adjusted earnings of $2.93 per share missed the $3.02 estimate. More troubling than the headline miss was the composition: Software growth fell to 5% from 11% in Q1, Consulting was flat, and Infrastructure contracted 7% versus prior guidance for a low-single-digit decline.

CEO Arvind Krishna's blunt investor letter acknowledged the company "faltered" and failed to anticipate the magnitude of a late-quarter shift in enterprise spending. Clients, facing anticipated price increases on supply-constrained AI hardware, redirected capital expenditure toward servers, storage, and memory in the final weeks of June. Several large software and mainframe deals that IBM had expected to close slipped beyond the quarter. The z17 mainframe cycle, which management had characterized as the strongest launch in IBM history, underperformed expectations, dragging down associated transaction processing software. The warning triggered immediate analyst repercussions: HSBC downgraded IBM to Reduce with a $191 target, Oppenheimer scrapped its $350 price target and moved to Perform, and Citigroup slashed its target from $375 to $255.

What Drove IBM Stock Performance Over the Last Quarter

IBM's quarterly decline reflects a broader investor reassessment of the company's positioning within the AI investment cycle. The first quarter had been a standout: software growth of 11%, infrastructure up 15%, and management confidently guiding for 5%-plus constant-currency revenue growth in 2026 underpinned by accelerating software momentum. The stock traded at roughly 26 times forward earnings — a significant premium reflecting confidence that IBM had successfully pivoted toward AI-driven growth.

That narrative began to crack well before the July 14 warning. Through June, IBM shares steadily eroded from $320 to $249 amid growing concern that enterprise AI budgets were flowing disproportionately toward hardware vendors such as MU and NVDA rather than software and consulting providers. Short interest rose 14.5% by June 30, and hedge fund ownership declined. The preliminary Q2 results confirmed those fears: the AI boom was accelerating, but the spending was landing on the wrong side of IBM's portfolio. While Red Hat grew 11% and Distributed Infrastructure surged 37% with a $500 million backlog, these bright spots were insufficient to offset mainframe weakness and deal slippage. The quarterly decline thus represents a valuation reset driven by the realization that IBM's software-centric AI thesis faces meaningful headwinds as enterprises prioritize hardware buildout.

Trending AI Robots

In a market environment as volatile as the one IBM is currently navigating, many traders and investors turn to data-driven tools to help identify opportunities and manage risk. Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots from a universe of hundreds that trade thousands of tickers. Only top-performing and strategically relevant bots appear in this section, providing users with visibility into automated strategies that span diverse timeframes, methodologies, and performance metrics. Each bot operates according to its own distinct logic — from swing trading and momentum-based approaches to longer-term trend-following systems — allowing users to explore AI-driven insights tailored to different market conditions. For those seeking an edge amid shifting sector dynamics, exploring the Trending AI Robots page can offer a window into how artificial intelligence is being applied to modern trading.

IBM Stock Forecast Drivers: What Investors Should Watch Next

The most immediate catalyst for IBM is its full second-quarter earnings release and conference call scheduled for July 22. Investors will scrutinize whether management revises its 2026 full-year guidance downward and whether the large deals that slipped in Q2 are characterized as delayed or lost entirely. Commentary on software growth reacceleration, Red Hat momentum, and the z17 cycle trajectory will be critical. Beyond earnings, the broader enterprise spending environment remains pivotal: if the shift toward AI hardware proves structural rather than temporary, IBM's software and consulting segments may face sustained budget pressure. Conversely, any easing of memory supply constraints could redirect spending back toward IBM's core offerings. Analyst sentiment remains divided — the consensus Moderate Buy rating and average $293 price target imply significant upside from current levels, but the recent downgrades underscore genuine concern about the durability of IBM's growth narrative. Additional factors to monitor include progress on IBM's quantum computing roadmap, generative AI consulting bookings, and the company's ability to close its $500 million distributed infrastructure backlog in the second half of the year.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations